Lilly thinks sentences for drug counterfeiters too "lenient"
This article was originally published in Scrip
Executive Summary
Lilly, which often sees its lifestyle erectile dysfunction drug Cialis (tadalafil) the target of drug counterfeits, appears to want stronger custodial sentences for those involved in the illegal activity. The comment comes after three UK men were sentenced up to 40 months on 25 February for trying to make half a million counterfeit Cialis tablets, with a street value of £1.6 million, from a residential flat in London.
You may also be interested in...
US FDA head Hamburg declares no one can inspect world on its own
The US Food and Drug Administration recently signalled its desire to work more closely with other drug regulators in assessing the quality of pharmaceutical manufacturing facilities around the world.
FDA's Hamburg declares no one can "inspect world on its own" for poor quality medicines
It seems as if the US FDA is softening its stance on assessing the quality of pharmaceutical manufacturing facilities around the world in future, with an apparent desire to work more closely with other drug regulators. However, incorporating the regulators from countries such as India, China and Japan into a global inspectorate still looks problematical.
Pharma and MSF agree on competition for cheap vaccines, but differ on pricing
Large pharmaceutical companies and Médecins sans Frontières may not often see eye-to-eye over access to medicines in poor countries. But it seems as if industry and the humanitarian body, a prominent critic, do agree that competition works in improving access to vaccines, even though they don't agree about the mechanisms of price setting.